Publications by authors named "Nathalie Colnot"

Article Synopsis
  • - This study investigates the potential of a new NRF2 activator, S217879, to treat metabolic-associated fatty liver disease (MAFLD) and fibrosis using a 3D model of patient-derived liver slices.
  • - After treating liver slices from MAFLD patients with S217879, researchers found no toxic effects and observed significant improvements in liver health, including reduced triglycerides, inflammation, and DNA damage compared to untreated samples.
  • - The results highlight that both S217879 and elafibranor, a standard treatment, effectively activate certain genes related to liver metabolism and antioxidant responses, with S217879 showing additional benefits in lowering inflammatory markers.
View Article and Find Full Text PDF

Background: Ileal pouch-anal anastomosis (IPAA) is the standard of care after total proctocolectomy for ulcerative colitis (UC). However, inflammation often develops in the pouch, leading to acute or recurrent/chronic pouchitis (R/CP). MicroRNAs (miRNA) are used as accurate diagnostic and predictive biomarkers in many human diseases, including inflammatory bowel diseases.

View Article and Find Full Text PDF

Background & Aims: Previous studies demonstrated that autophagy is protective in hepatocytes and macrophages, but detrimental in hepatic stellate cells in chronic liver diseases. The role of autophagy in liver sinusoidal endothelial cells (LSECs) in non-alcoholic steatohepatitis (NASH) is unknown. Our aim was to analyze the potential implication of autophagy in LSECs in NASH and liver fibrosis.

View Article and Find Full Text PDF

Objective: Previous studies suggested that microRNA-21 may be upregulated in the liver in non-alcoholic steatohepatitis (NASH), but its role in the development of this disease remains unknown. This study aimed to determine the role of microRNA-21 in NASH.

Design: We inhibited or suppressed microRNA-21 in different mouse models of NASH: (a) low-density lipoprotein receptor-deficient () mice fed a high-fat diet and treated with antagomir-21 or antagomir control; (b) microRNA-21-deficient and wild-type mice fed a methionine-choline-deficient (MCD) diet; (c) peroxisome proliferation-activator receptor α (PPARα)-deficient mice fed an MCD diet and treated with antagomir-21 or antagomir control.

View Article and Find Full Text PDF

Liver biopsy of metastatic pancreatic endocrine tumors allows confirmation of the diagnosis and assessment of prognosis. However, sampling variability is a potential limitation. Our aim was to use the tissue microarray technique to assess the heterogeneity of three prognostic markers, ie, MIB-1 proliferation index, microvascular density and somatostatin receptor type 2, inside single or between synchronous or metachronous liver metastases of pancreatic endocrine tumors.

View Article and Find Full Text PDF

Objective: To prospectively evaluate the accuracy of frozen sectioning (FS) of the pancreatic transection margin and its influence on surgery during resection of intraductal papillary and mucinous neoplasms (IPMNs).

Summary Background Data: Preoperative assessment of IPMN extension is difficult and transection margin is frequently tumoral on the surgical specimen.

Patients And Methods: FS was performed in 127 patients who underwent partial pancreatectomy for IPMN from 1996 to 2004, corresponding to 90 pancreaticoduodenectomies (1-4 successive FS; total = 132), 25 distal pancreatectomies (1-2 FS; total = 27), and 12 medial pancreatectomies (2-4 FS; total = 29).

View Article and Find Full Text PDF